Latest Financials News

EROAD Limited reported solid financial results for FY25, with revenue up 6.8% to NZ$194.4 million and a substantial improvement in free cash flow to NZ$16 million. The company’s strategic focus on enterprise fleet growth and innovation underpins a confident FY26 guidance.

Yowie Group has lodged a formal application with the Takeovers Panel to block Keybridge Capital from convening a shareholder meeting aimed at replacing Yowie’s board, accusing Keybridge of trying to frustrate its takeover offer.

Pioneer Lithium has completed the second tranche of its capital raising, issuing 1.6 million shares to directors following shareholder approval. This move strengthens the company’s capital base as it advances its lithium exploration ambitions.

Osteopore Limited has drawn down an additional A$500,000 from the first tranche of its redeemable convertible notes, bringing total subscriptions close to the A$5 million tranche limit. The funds will support ongoing operations and future growth initiatives.

Nufarm Finance (NZ) Limited reported a 4.1% increase in net profit after tax to NZD 10.35 million for the half-year ended 31 March 2025, driven by higher interest rates. The company declared an interim distribution of NZD 4.31 per security, payable in October 2024.

Chorus Limited has lodged a replacement Product Disclosure Statement for its $170 million Capital Notes offer, confirming S&P’s equity content treatment and updating key offer dates and terms.

Reef Casino Trust reported stable 2024 financial results with steady distributions, while confidential takeover proposals from two groups are under board review. Operational challenges include rising regulatory costs and inflationary pressures.

Lykos Metals announces key leadership changes with David Wheeler stepping up as Non-Executive Chair and Petar Tomasevic taking the helm as Interim CEO, signaling a strategic pivot as the company advances in the Balkan region.

Reef Casino Trust projects a drop in first-half distributable profit for 2025, citing stable revenues but increased regulatory and transaction-related expenses.

Neuren Pharmaceuticals has approved a significant long-term equity incentive plan tied to critical clinical and regulatory milestones for its drug candidate NNZ-2591, reinforcing management’s commitment to shareholder value.

GreenHy2 Limited has broadened its renewable energy storage portfolio by integrating graphene-based hybrid supercapacitor batteries, reporting robust FY24 growth and advancing key customer trials.

Auric Mining Ltd has unveiled a capital raising plan aimed at boosting gold production and expanding its resource base through 2028, including key acquisitions and exploration initiatives.